← Back to Search

Home Blood Pressure Monitoring for Liver Cirrhosis (WATCH Trial)

N/A

Recruiting

Led By Giuseppe Cullaro, MD, MAS

Research Sponsored by University of California, San Francisco

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline and 24 weeks

Summary

This trial tests if home blood pressure devices can help improve care for cirrhosis patients with severe symptoms.

Who is the study for?

This trial is for patients with advanced liver cirrhosis (Child Pugh Score ≥ 7), which means their liver is severely scarred and not working well. The study aims to help manage their condition using home blood pressure monitoring.

What is being tested?

The trial is testing if using a Withings Home Blood Pressure Device and Scale can improve the treatment of decompensated cirrhosis compared to standard care alone. It's a randomized single-blind study, meaning some patients will use the device while others won't, and they won't know which group they're in.

What are the potential side effects?

Since this trial focuses on monitoring rather than medication, direct side effects from interventions are minimal. However, there may be indirect effects related to changes in management of midodrine based on blood pressure readings.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline and 24 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline and 24 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and 24 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Change in Mean Arterial Pressure

Secondary study objectives

Change in Ascites Burden

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: Home Blood Pressure and Scale Monitoring to Inform Clinical DecisionsExperimental Treatment1 Intervention

This arm will receive a home blood pressure monitor and scale. These data will be reviewed weekly and these data will be shared with the treating provider to inform clinical decisions.

Group II: Standard of CarePlacebo Group1 Intervention

This arm will receive a home blood pressure monitor and scale; however, these data will not be shared with their treating provider in real-time.

Do I qualify?Apply below to find out